zedie.wordpress.com
Ibrutinib and Rituximab for Untreated CLL: ‘Practice Changing’
The combination of ibrutinib (Imbruvica, Pharmacyclics/Janssen) and rituximab (Rituxan, Roche/Genentech) beat the current gold standard of fludarabine, cyclophosphamide, and rituximab (FCR) for you…